Brief: Third Party Withdraws Appeal Related To Cantargia Patent
Nov 20 (Reuters) - Cantargia AB CANTA.ST :
* THIRD PARTY WITHDRAWS APPEAL RELATED TO CANTARGIA PATENT
* PATENT REMAINS IN FORCE WITH CLAIMS ENCOMPASSING
CANTARGIA'S
LEAD ASSET NADUNOLIMAB AND RELATED VARIANT ANTIBODIES
Source text for Eikon: ID:nMFN584c2M
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Cantargia AB
See all newsBrief: Cantargia Publishes Nadunolimab CANFOUR Study Data
Brief: Cantargia Announces Outcome Of Rights Issue, Raising About SEK 75 Mln
Brief: Cantargia Carries Out Rights Issue, Enters Loan Agreement
Brief: Cantargia Q1 Operating Loss Narrows To SEK 36.9 Mln
Brief: Cantargia: Early Results From Phase 1B/2A Nadunolimab Trial In MDS And AML